<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">r-n-j</journal-id><journal-title-group><journal-title xml:lang="ru">Российский неврологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian neurological journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2658-7947</issn><issn pub-type="epub">2686-7192</issn><publisher><publisher-name>МИА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/2658-7947-2024-29-6-20-26</article-id><article-id custom-type="elpub" pub-id-type="custom">r-n-j-633</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Острая моторная аксональная невропатия: особенности диагностики, лечения и реабилитации</article-title><trans-title-group xml:lang="en"><trans-title>Acute motor axonal neuropathy: features of diagnosis, treatment and rehabilitation</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0448-7402</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Войтенков</surname><given-names>В. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Voitenkov</surname><given-names>V. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Санкт-Петербург</p><p>Москва</p></bio><bio xml:lang="en"><p>St. Petersburg</p><p>Moscow</p></bio><email xlink:type="simple">vlad203@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1838-9304</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самойлова</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Samojlova</surname><given-names>I. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>St. Petersburg</p></bio><email xlink:type="simple">niidi@niidi.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8789-4750</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скрипченко</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Skripchenko</surname><given-names>E. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>St. Petersburg</p></bio><email xlink:type="simple">wwave@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5839-1433</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черкашина</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Cherkashina</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>St. Petersburg</p></bio><email xlink:type="simple">niidi@niidi.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6180-4403</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Климкин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Klimkin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>St. Petersburg</p></bio><email xlink:type="simple">klinkinpark@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8924-5300</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ирикова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Irikova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>St. Petersburg</p></bio><email xlink:type="simple">dr.bedova@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2128-0737</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вербенко</surname><given-names>П. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Verbenko</surname><given-names>P. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>St. Petersburg</p></bio><email xlink:type="simple">verbenkops@mail.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства; Академия постдипломного образования Федерального государственного бюджетного учреждения «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pediatric Research and Clinical Center for Infectious Diseases; Academy of postgraduate education under FSBU FSCC of FMBA of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pediatric Research and Clinical Center for Infectious Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства; Санкт-Петербургский государственный педиатрический медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pediatric Research and Clinical Center for Infectious Diseases; St. Petersburg State Pediatric Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Санкт-Петербургский государственный педиатрический медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>St. Petersburg State Pediatric Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>01</month><year>2025</year></pub-date><volume>29</volume><issue>6</issue><fpage>20</fpage><lpage>26</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Войтенков В.Б., Самойлова И.Г., Скрипченко Е.Ю., Черкашина И.В., Климкин А.В., Ирикова М.А., Вербенко П.С., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Войтенков В.Б., Самойлова И.Г., Скрипченко Е.Ю., Черкашина И.В., Климкин А.В., Ирикова М.А., Вербенко П.С.</copyright-holder><copyright-holder xml:lang="en">Voitenkov V.B., Samojlova I.G., Skripchenko E.Y., Cherkashina I.V., Klimkin A.V., Irikova M.A., Verbenko P.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.r-n-j.com/jour/article/view/633">https://www.r-n-j.com/jour/article/view/633</self-uri><abstract><p>Острая аксональная моторная невропатия (ОМАН) — аксональный вариант синдрома Гийена-Барре, характеризующийся острым поражением двигательных волокон периферических нервов. В остром периоде терапия состоит из специфических и неспецифических методов лечения. К специфическим относятся операции высокообъемного программного плазмафереза и курсы высокодозной внутривенной иммунотерапии препаратами иммуноглобулинов G. Неспецифические методы заключаются в симптоматической терапии. В период реконвалесценции целесообразно более раннее назначение восстановительного лечения с привлечением мультидисциплинарной бригады специалистов.</p></abstract><trans-abstract xml:lang="en"><p>Acute axonal motor neuropathy (AMAN) is an axonal variant of Guillain-Barré syndrome, characterized by acute damage of motor fibers of peripheral nerves. In the acute period, therapy involves the use of specific and nonspecific methods. Specific methods include operations of high-volume program plasmapheresis and courses of high-dose intravenous immunotherapy with immunoglobulin class G preparations. Nonspecific methods consist of symptomatic therapy. It is very important to start rehabilitation treatment with a multidisciplinary team of specialists as early as possible in the period of reconvalescence.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром Гийена-Барре</kwd><kwd>острая моторная аксональная невропатия</kwd><kwd>реабилитация</kwd><kwd>терапия внутривенным иммуноглобулином человеческим</kwd><kwd>электронейромиография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Guillain-Barré syndrome</kwd><kwd>acute motor axonal neuropathy</kwd><kwd>rehabilitation</kwd><kwd>therapy with intravenous human immunoglobulin</kwd><kwd>electroneuromyography</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">van Doorn P.A., Van den Bergh P.Y.K., Hadden R.D.M., Avau B., Vankrunkelsven P., Attarian S., Blomkwist-Markens P.H., Cornblath D.R., Goedee H.S., Harbo T., Jacobs B.C., Kusunoki S., Lehmann H.C., Lewis R.A., Lunn M.P., Nobile-Orazio E., Querol L., Rajabally Y.A., Umapathi T., Topaloglu H.A., Willison H.J. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome. Eur J Neurol. 2023;30(12):3646–3674. https://doi.org/10.1111/ene.16073</mixed-citation><mixed-citation xml:lang="en">van Doorn P.A., Van den Bergh P.Y.K., Hadden R.D.M., Avau B., Vankrunkelsven P., Attarian S., Blomkwist-Markens P.H., Cornblath D.R., Goedee H.S., Harbo T., Jacobs B.C., Kusunoki S., Lehmann H.C., Lewis R.A., Lunn M.P., Nobile-Orazio E., Querol L., Rajabally Y.A., Umapathi T., Topaloglu H.A., Willison H.J. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome. Eur J Neurol. 2023;30(12):3646–3674. https://doi.org/10.1111/ene.16073</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shastri A., Al Aiyan A., Kishore U., Farrugia M.E. Immune-Mediated Neuropathies: Pathophysiology and Management. Int J Mol Sci. 2023;24(8):7288. https://doi.org/10.3390/ijms24087288</mixed-citation><mixed-citation xml:lang="en">Shastri A., Al Aiyan A., Kishore U., Farrugia M.E. Immune-Mediated Neuropathies: Pathophysiology and Management. Int J Mol Sci. 2023;24(8):7288. https://doi.org/10.3390/ijms24087288</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Collet R., Caballero-Ávila M., Querol L. Clinical and pathophy-siological implications of autoantibodies in autoimmune neuropathies. Rev Neurol (Paris). 2023;179(8):831–843. https://doi.org/10.1016/j.neurol.2023.02.064</mixed-citation><mixed-citation xml:lang="en">Collet R., Caballero-Ávila M., Querol L. Clinical and pathophy-siological implications of autoantibodies in autoimmune neuropathies. Rev Neurol (Paris). 2023;179(8):831–843. https://doi.org/10.1016/j.neurol.2023.02.064</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Censi S., Bisaccia G., Gallina S., Tomassini V., Uncini A. Guillain-Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’. Eur J Neurol. 2024;31(2):e16094. https://doi.org/10.1111/ene.16094</mixed-citation><mixed-citation xml:lang="en">Censi S., Bisaccia G., Gallina S., Tomassini V., Uncini A. Guillain-Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’. Eur J Neurol. 2024;31(2):e16094. https://doi.org/10.1111/ene.16094</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Filosto M., Cotti Piccinelli S., Gazzina S., Foresti C., Frigeni B., Servalli M.C., Sessa M., Cosentino G., Marchioni E., Ravaglia S., Briani C., Castellani F., Zara G., Bianchi F., Del Carro U., Fazio R., Filippi M., Magni E., Natalini G., Palmerini F., Perotti A.M., Bellomo A., Osio M., Nascimbene C., Carpo M., Rasera A., Squintani G., Doneddu P.E., Bertasi V., Cotelli M.S., Bertolasi L., Fabrizi G.M., Ferrari S., Ranieri F., Caprioli F., Grappa E., Manganotti P., Bellavita G., Furlanis G., De Maria G., Leggio U., Poli L., Rasulo F., Latronico N., Nobile-Orazio E., Beghi E., Padovani A., Uncini A. Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study. Eur J Neurol. 2022;29(11):3358–3367. https://doi.org/10.1111/ene.15497</mixed-citation><mixed-citation xml:lang="en">Filosto M., Cotti Piccinelli S., Gazzina S., Foresti C., Frigeni B., Servalli M.C., Sessa M., Cosentino G., Marchioni E., Ravaglia S., Briani C., Castellani F., Zara G., Bianchi F., Del Carro U., Fazio R., Filippi M., Magni E., Natalini G., Palmerini F., Perotti A.M., Bellomo A., Osio M., Nascimbene C., Carpo M., Rasera A., Squintani G., Doneddu P.E., Bertasi V., Cotelli M.S., Bertolasi L., Fabrizi G.M., Ferrari S., Ranieri F., Caprioli F., Grappa E., Manganotti P., Bellavita G., Furlanis G., De Maria G., Leggio U., Poli L., Rasulo F., Latronico N., Nobile-Orazio E., Beghi E., Padovani A., Uncini A. Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study. Eur J Neurol. 2022;29(11):3358–3367. https://doi.org/10.1111/ene.15497</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S., Zhang W.W., Jia L., Zhang H.L. Guillain-Barré syndrome: immunopathogenesis and therapeutic targets. Expert Opin Ther Targets. 2024;28(3):131–143. https://doi.org/10.1080/14728222.2024.2330435</mixed-citation><mixed-citation xml:lang="en">Liu S., Zhang W.W., Jia L., Zhang H.L. Guillain-Barré syndrome: immunopathogenesis and therapeutic targets. Expert Opin Ther Targets. 2024;28(3):131–143. https://doi.org/10.1080/14728222.2024.2330435</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rose M.Q., Santos C.D., Rubin D.I., Siegel J.L., Freeman W.D. Guillain-Barré Syndrome After Acute Hepatitis E Infection: A Case Report and Literature Review. Crit Care Nurse. 2021;41(4):47–53. https://doi.org/10.4037/ccn2021129</mixed-citation><mixed-citation xml:lang="en">Rose M.Q., Santos C.D., Rubin D.I., Siegel J.L., Freeman W.D. Guillain-Barré Syndrome After Acute Hepatitis E Infection: A Case Report and Literature Review. Crit Care Nurse. 2021;41(4):47–53. https://doi.org/10.4037/ccn2021129</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dalugama C., Shelton J., Ekanayake M., Gawarammana I.B. Dengue fever complicated with Guillain-Barré syndrome: a case report and review of the literature. J Med Case Rep. 2018;12:137. https://doi.org/10.1186/s13256-018-1626-y</mixed-citation><mixed-citation xml:lang="en">Dalugama C., Shelton J., Ekanayake M., Gawarammana I.B. Dengue fever complicated with Guillain-Barré syndrome: a case report and review of the literature. J Med Case Rep. 2018;12:137. https://doi.org/10.1186/s13256-018-1626-y</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lim C.S., Kaisbain N., Lim W.J. A Rare Combination: Dengue Fever Complicated With Guillain-Barre Syndrome. Cureus. 2023;15(6):e40957. https://doi.org/10.7759/cureus.40957</mixed-citation><mixed-citation xml:lang="en">Lim C.S., Kaisbain N., Lim W.J. A Rare Combination: Dengue Fever Complicated With Guillain-Barre Syndrome. Cureus. 2023;15(6):e40957. https://doi.org/10.7759/cureus.40957</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Doets A.Y., Verboon C., van den Berg B., Harbo T., Cornblath D.R., Willison H.J., Islam Z., Attarian S., Barroso F.A., Bateman K., Benedetti L., van den Bergh P., Casasnovas C., Cavaletti G., Chavada G., Claeys K.G., Dardiotis E., Davidson A., van Doorn P.A., Feasby T.E., Galassi G., Gorson K.C., Hartung H.P., Hsieh S.T., Hughes R.A.C., Illa I., Islam B., Kusunoki S., Kuwabara S., Lehmann H.C., Miller J.A.L., Mohammad Q.D., Monges S., Nobile Orazio E., Pardo J., Pereon Y., Rinaldi S., Querol L., Reddel S.W., Reisin R.C., Shahrizaila N., Sindrup S.H., Waqar W., Jacobs B.C.; IGOS Consortium. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866–2877. https://doi.org/10.1093/brain/awy232</mixed-citation><mixed-citation xml:lang="en">Doets A.Y., Verboon C., van den Berg B., Harbo T., Cornblath D.R., Willison H.J., Islam Z., Attarian S., Barroso F.A., Bateman K., Benedetti L., van den Bergh P., Casasnovas C., Cavaletti G., Chavada G., Claeys K.G., Dardiotis E., Davidson A., van Doorn P.A., Feasby T.E., Galassi G., Gorson K.C., Hartung H.P., Hsieh S.T., Hughes R.A.C., Illa I., Islam B., Kusunoki S., Kuwabara S., Lehmann H.C., Miller J.A.L., Mohammad Q.D., Monges S., Nobile Orazio E., Pardo J., Pereon Y., Rinaldi S., Querol L., Reddel S.W., Reisin R.C., Shahrizaila N., Sindrup S.H., Waqar W., Jacobs B.C.; IGOS Consortium. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866–2877. https://doi.org/10.1093/brain/awy232</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Скрипченко Н.В., Вильниц А.А., Егорова Е.С., Скрипченко Е.Ю., Климкин А.В., Войтенков В.Б., Конев А.И., Алексеева Л.А. Неотложные состояния при нейроинфекциях у детей. Российский педиатрический журнал. 2022;3(1):287. https://www.rospedj.ru/jour/article/view/447/377 (доступ не ограничен).</mixed-citation><mixed-citation xml:lang="en">Skripchenko N.V., Vilnitz A.A., Egorova E.S., Skripchenko E.Yu., Klimkin A.V., Voytenkov V.B., Konev A.I., Alekseeva L.A. Pediatric neuroinfection emergencies. Russian Pediatric Journal (Rossiiskii pediatricheskii zhurnal). 2022;3(1):287 (Russian). https://www.rospedj.ru/jour/article/view/447/377 (доступ не ограничен).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Carpentier V.T., Le Guennec L., Fall S.A.A., Viala K., Demeret S., Weiss N. Syndrome de Guillain-Barré: physiopathologie et aspects diagnostiques [Pathophysiological and diagnostic aspects of Guillain-Barré syndrome]. Rev Med Interne. 2022;43(7):419–428. https://doi.org/10.1016/j.revmed.2021.12.005</mixed-citation><mixed-citation xml:lang="en">Carpentier V.T., Le Guennec L., Fall S.A.A., Viala K., Demeret S., Weiss N. Syndrome de Guillain-Barré: physiopathologie et aspects diagnostiques [Pathophysiological and diagnostic aspects of Guillain-Barré syndrome]. Rev Med Interne. 2022;43(7):419–428. https://doi.org/10.1016/j.revmed.2021.12.005</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bazán-Rodríguez L., Ruiz-Avalos J.A., de Saráchaga A.J., Martinez-Jimenez E., López-Hernández J.C., Vargas-Cañas S. Dysautonomia and related outcomes in Guillain-Barre syndrome. Auton Neurosci. 2023;245:103070. https://doi.org/10.1016/j.autneu.2022.103070</mixed-citation><mixed-citation xml:lang="en">Bazán-Rodríguez L., Ruiz-Avalos J.A., de Saráchaga A.J., Martinez-Jimenez E., López-Hernández J.C., Vargas-Cañas S. Dysautonomia and related outcomes in Guillain-Barre syndrome. Auton Neurosci. 2023;245:103070. https://doi.org/10.1016/j.autneu.2022.103070</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chakraborty T., Kramer C.L., Wijdicks E.F.M., Rabinstein A.A. Dysautonomia in Guillain-Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes. Neurocrit Care. 2020;32(1):113–120. https://doi.org/10.1007/s12028-019-00781-w</mixed-citation><mixed-citation xml:lang="en">Chakraborty T., Kramer C.L., Wijdicks E.F.M., Rabinstein A.A. Dysautonomia in Guillain-Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes. Neurocrit Care. 2020;32(1):113–120. https://doi.org/10.1007/s12028-019-00781-w</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng Y., Liu K., Li C., Zhang W., Wu X., Fang S. Risk Factors for Mechanical Ventilation in Patients with Guillain-Barré Syndrome. Neurocrit Care. 2022;37(1):121–128. https://doi.org/10.1007/s12028-022-01457-8</mixed-citation><mixed-citation xml:lang="en">Cheng Y., Liu K., Li C., Zhang W., Wu X., Fang S. Risk Factors for Mechanical Ventilation in Patients with Guillain-Barré Syndrome. Neurocrit Care. 2022;37(1):121–128. https://doi.org/10.1007/s12028-022-01457-8</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Luijten L.W.G., Doets A.Y., Arends S., Dimachkie M.M., Gorson K.C., Islam B., Kolb N.A., Kusunoki S., Papri N., Waheed W., Walgaard C., Yamagishi Y., Lingsma H., Jacobs B.C. IGOS Consortium. Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2022;94(4):300–308. https://doi.org/10.1136/jnnp-2022-329937</mixed-citation><mixed-citation xml:lang="en">Luijten L.W.G., Doets A.Y., Arends S., Dimachkie M.M., Gorson K.C., Islam B., Kolb N.A., Kusunoki S., Papri N., Waheed W., Walgaard C., Yamagishi Y., Lingsma H., Jacobs B.C. IGOS Consortium. Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2022;94(4):300–308. https://doi.org/10.1136/jnnp-2022-329937</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Galassi G., Mazzoli M., Ariatti A., Bedin R., Marzullo D., Bastia E., Agnoletto V., Gozzi M., Valzania F., Meletti S., Marchioni A. Predictors of respiratory failure in Guillain-Barré syndrome: a 22 year cohort study from a single Italian centre. Eur J Neurol. 2024;31(1):e16090. https://doi.org/10.1111/ene.16090</mixed-citation><mixed-citation xml:lang="en">Galassi G., Mazzoli M., Ariatti A., Bedin R., Marzullo D., Bastia E., Agnoletto V., Gozzi M., Valzania F., Meletti S., Marchioni A. Predictors of respiratory failure in Guillain-Barré syndrome: a 22 year cohort study from a single Italian centre. Eur J Neurol. 2024;31(1):e16090. https://doi.org/10.1111/ene.16090</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wachira V.K., Farinasso C.M., Silva R.B., Peixoto H.M., de Oliveira M.R.F. Incidence of Guillain-Barré syndrome in the world between 1985 and 2020: A systematic review. Glob Epidemiol. 2023;5:100098. https://doi.org/10.1016/j.gloepi.2023.100098</mixed-citation><mixed-citation xml:lang="en">Wachira V.K., Farinasso C.M., Silva R.B., Peixoto H.M., de Oliveira M.R.F. Incidence of Guillain-Barré syndrome in the world between 1985 and 2020: A systematic review. Glob Epidemiol. 2023;5:100098. https://doi.org/10.1016/j.gloepi.2023.100098</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hagen K.M., Ousman S.S. The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System. Front Aging Neurosci. 2021;12:613628. https://doi.org/10.3389/fnagi.2020.613628</mixed-citation><mixed-citation xml:lang="en">Hagen K.M., Ousman S.S. The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System. Front Aging Neurosci. 2021;12:613628. https://doi.org/10.3389/fnagi.2020.613628</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Супонева Н.А., Пирадов М.А., Никитин С.С., Тимченко О.Л., Грачева Л.А., Быкова Л.П., Лапин С.В., Федькина Ю.А., Костырева М.В., Шабалина А.В., Гришина Д.А. Патогенетическая и прогностическая роль аутоантител к ганглиозидам периферических нервов при синдроме Гийена-Барре. Анналы клинической и экспериментальной неврологии. 2013;7(1):4–11. https://cyberleninka.ru/article/n/patogeneticheskaya-i-prognosticheskaya-rol-autoantitel-k-gangliozidam-perifericheskih-nervov-pri-sindrome-giyena-barre. (доступ не ограничен).</mixed-citation><mixed-citation xml:lang="en">Suponeva N.A., Piradov M.A., Nikitin S.S., Timchenko O.L., Gracheva L.A., Bykova L.P., Lapin S.V., Fed’kina Yu.A., Kostyreva M.V., Shabalina A.V., Grishina D.A. Pathogenetic and prognostic role of autoantibodies to peripheral nerve gangliosides in Guillain-Barré syndrome. Annals of Clinical and Experimental Neurology (Annaly klinicheskoi i eksperimental’noi nevrologii). 2013;7(1):4–11 (Russian). https://cyberleninka.ru/article/n/patogeneticheskaya-i-prognosticheskaya-rol-autoantitel-k-gangliozidam-perifericheskih-nervov-pri-sindrome-giyena-barre. (доступ не ограничен).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Козырева А.А., Бембеева Р.Т., Дружинина Е.С., Заваденко Н.Н. Синдром Гийена-Барре у детей. Журнал неврологии и психиатрии им. С.С. Корсакова. 2023;123(9):20–32. https://doi.org/10.17116/jnevro202312309220</mixed-citation><mixed-citation xml:lang="en">Kozyreva A.A., Bembeeva R.T., Druzhinina E.S., Zavadenko N.N. Guillain-Barre syndrome in children. S.S. Korsakov Journal of Neurology and Psychiatry (Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova). 2023;123(9):20–32 (Russian). https://doi.org/10.17116/jnevro202312309220</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wu X., Shen D., Li T., Zhang B., Li C., Mao M., Zhao J., Liu K., Zhang H.L. Distinct Clinical Characteristics of Pediatric Guillain-Barré Syndrome: A Comparative Study between Children and Adults in Northeast China. PLoS One. 2016;11(3):e0151611. https://doi.org/10.1371/journal.pone.0151611</mixed-citation><mixed-citation xml:lang="en">Wu X., Shen D., Li T., Zhang B., Li C., Mao M., Zhao J., Liu K., Zhang H.L. Distinct Clinical Characteristics of Pediatric Guillain-Barré Syndrome: A Comparative Study between Children and Adults in Northeast China. PLoS One. 2016;11(3):e0151611. https://doi.org/10.1371/journal.pone.0151611</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Shibeshi M.S., Mengesha A.A., Gari K.T. Pediatric Guillain-Barré Syndrome in a Resource Limited Setting: Clinical Features, Diagnostic and Management Challenges, and Hospital Outcome. Pediatric Health Med Ther. 2023;14:107–115. https://doi.org/10.2147/PHMT.S401461</mixed-citation><mixed-citation xml:lang="en">Shibeshi M.S., Mengesha A.A., Gari K.T. Pediatric Guillain-Barré Syndrome in a Resource Limited Setting: Clinical Features, Diagnostic and Management Challenges, and Hospital Outcome. Pediatric Health Med Ther. 2023;14:107–115. https://doi.org/10.2147/PHMT.S401461</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Jin M., Liu J., Liu K., Zhao L., Zhao Z., Sun S. Sympathetic skin response (SSR) in pediatric Guillain-Barré syndrome. Front Neurol. 2023;14:1177394. https://doi.org/10.3389/fneur.2023.1177394</mixed-citation><mixed-citation xml:lang="en">Jin M., Liu J., Liu K., Zhao L., Zhao Z., Sun S. Sympathetic skin response (SSR) in pediatric Guillain-Barré syndrome. Front Neurol. 2023;14:1177394. https://doi.org/10.3389/fneur.2023.1177394</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Al Amrani F., Al-Abdwani R., Al Rashdi F., Al-Ajmi E., Al Futaisi A. Guillain-Barré Syndrome Associated with SARS-CoV-2 in Two Pediatric Patients. Sultan Qaboos Univ Med J. 2023;23(3):400–404. https://doi.org/10.18295/squmj.5.2022.040</mixed-citation><mixed-citation xml:lang="en">Al Amrani F., Al-Abdwani R., Al Rashdi F., Al-Ajmi E., Al Futaisi A. Guillain-Barré Syndrome Associated with SARS-CoV-2 in Two Pediatric Patients. Sultan Qaboos Univ Med J. 2023;23(3):400–404. https://doi.org/10.18295/squmj.5.2022.040</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Akçay N., Menentoğlu M.E., Bektaş G., Şevketoğlu E. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child. J Med Virol. 2021;93(9):5599–5602. https://doi.org/10.1002/jmv.27018</mixed-citation><mixed-citation xml:lang="en">Akçay N., Menentoğlu M.E., Bektaş G., Şevketoğlu E. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child. J Med Virol. 2021;93(9):5599–5602. https://doi.org/10.1002/jmv.27018</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Pourbakhtyaran E., Heidari M., Akbari M.G., Mohammadi M., Badv R.S., Zamani G., Tavasoli A.R., Rezaei Z., Mamishi S., Haji Esmaeil Memar E., Hosseiny S.M.M., Ghabeli H., Haghighi R., Ashrafi M.R. Childhood Guillain-Barre syndrome in the SARS-CoV-2 era: Is there any causative relation? Clin Case Rep. 2022;10(12):e6772. https://doi.org/10.1002/ccr3.6772</mixed-citation><mixed-citation xml:lang="en">Pourbakhtyaran E., Heidari M., Akbari M.G., Mohammadi M., Badv R.S., Zamani G., Tavasoli A.R., Rezaei Z., Mamishi S., Haji Esmaeil Memar E., Hosseiny S.M.M., Ghabeli H., Haghighi R., Ashrafi M.R. Childhood Guillain-Barre syndrome in the SARS-CoV-2 era: Is there any causative relation? Clin Case Rep. 2022;10(12):e6772. https://doi.org/10.1002/ccr3.6772</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Levison L.S., Thomsen R.W., Markvardsen L.K., Christensen D.H., Sindrup S.H., Andersen H. Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort. Pediatr Neurol. 2020;107:57–63. https://doi.org/10.1016/j.pediatrneurol.2020.01.017</mixed-citation><mixed-citation xml:lang="en">Levison L.S., Thomsen R.W., Markvardsen L.K., Christensen D.H., Sindrup S.H., Andersen H. Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort. Pediatr Neurol. 2020;107:57–63. https://doi.org/10.1016/j.pediatrneurol.2020.01.017</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Kobayashi Takahashi Y., Hayakawa I., Abe Y. Diagnostic odyssey of Guillain-Barré syndrome in children. Brain Dev. 2024;46(2):108–113. https://doi.org/10.1016/j.braindev.2023.10.004</mixed-citation><mixed-citation xml:lang="en">Kobayashi Takahashi Y., Hayakawa I., Abe Y. Diagnostic odyssey of Guillain-Barré syndrome in children. Brain Dev. 2024;46(2):108–113. https://doi.org/10.1016/j.braindev.2023.10.004</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Tiwari I., Alam A., Kanta C., Koonwar S., Garg R.K., Pandey S., Jain A., Kumar R. Clinical Profile and Predictors of Mechanical Ventilation in Guillain-Barre Syndrome in North Indian Children. J Child Neurol. 2021;36(6):453–460. https://doi.org/10.1177/0883073820978020</mixed-citation><mixed-citation xml:lang="en">Tiwari I., Alam A., Kanta C., Koonwar S., Garg R.K., Pandey S., Jain A., Kumar R. Clinical Profile and Predictors of Mechanical Ventilation in Guillain-Barre Syndrome in North Indian Children. J Child Neurol. 2021;36(6):453–460. https://doi.org/10.1177/0883073820978020</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Brisset M., Nicolas G. Peripheral neuropathies and aging. Geriatr Psychol Neuropsychiatr Vieil. 2018;16(4):409–413. https://doi.org/10.1684/pnv.2018.0768</mixed-citation><mixed-citation xml:lang="en">Brisset M., Nicolas G. Peripheral neuropathies and aging. Geriatr Psychol Neuropsychiatr Vieil. 2018;16(4):409–413. https://doi.org/10.1684/pnv.2018.0768</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Peric S., Berisavac I., Stojiljkovic Tamas O., Rajic S., Babic M., Cvijanovic M., Dominovic-Kovacevic A., Basta I., Beslac-Bumbasirevic L., Lavrnic D. Guillain-Barré syndrome in the elderly. J Peripher Nerv Syst. 2016;21(2):105–110. https://doi.org/10.1111/jns.12163</mixed-citation><mixed-citation xml:lang="en">Peric S., Berisavac I., Stojiljkovic Tamas O., Rajic S., Babic M., Cvijanovic M., Dominovic-Kovacevic A., Basta I., Beslac-Bumbasirevic L., Lavrnic D. Guillain-Barré syndrome in the elderly. J Peripher Nerv Syst. 2016;21(2):105–110. https://doi.org/10.1111/jns.12163</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Briseño-Godínez M.E., Arauz A., López-Hernández J.C., de Saráchaga A.J., Pérez-Valdez E.Y., May-Más R.N., López-Hernández G., Bazán-Rodriguez L., Galnares-Olalde J.A., León-Manríquez E., Vargas-Cañas E.S. Prognostic Factors in Elderly Patients With Guillain-Barré Syndrome: Does Age Matter? Neurohospitalist. 2021;11(4):303–309. https://doi.org/10.1177/19418744211002676</mixed-citation><mixed-citation xml:lang="en">Briseño-Godínez M.E., Arauz A., López-Hernández J.C., de Saráchaga A.J., Pérez-Valdez E.Y., May-Más R.N., López-Hernández G., Bazán-Rodriguez L., Galnares-Olalde J.A., León-Manríquez E., Vargas-Cañas E.S. Prognostic Factors in Elderly Patients With Guillain-Barré Syndrome: Does Age Matter? Neurohospitalist. 2021;11(4):303–309. https://doi.org/10.1177/19418744211002676</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Minamino M., Miyamoto K., Kuwahara M., Yoshikawa K., Koh J., Kusunoki S., Nagai Y., Ito H. Characteristics of Guillain-Barré syndrome in super-elderly individuals. J Neurol. 2023; 270(4):2191–2196. https://doi.org/10.1007/s00415-023-11567-8</mixed-citation><mixed-citation xml:lang="en">Minamino M., Miyamoto K., Kuwahara M., Yoshikawa K., Koh J., Kusunoki S., Nagai Y., Ito H. Characteristics of Guillain-Barré syndrome in super-elderly individuals. J Neurol. 2023; 270(4):2191–2196. https://doi.org/10.1007/s00415-023-11567-8</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kim S., Han H.J., Shin H.Y., Kim S.W. Old age and multiple comorbidity are associated with delayed diagnosis of Guillain-Barre syndrome. Sci Rep. 2022;12(1):9913. https://doi.org/10.1038/s41598-022-14184-z</mixed-citation><mixed-citation xml:lang="en">Kim S., Han H.J., Shin H.Y., Kim S.W. Old age and multiple comorbidity are associated with delayed diagnosis of Guillain-Barre syndrome. Sci Rep. 2022;12(1):9913. https://doi.org/10.1038/s41598-022-14184-z</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Bose S., Loo L.K., Rajabally Y.A. Causes and consequences of diagnostic delay in Guillain-Barré syndrome in a UK tertiary center. Muscle Nerve. 2022;65(5):547–552. https://doi.org/10.1002/mus.27506</mixed-citation><mixed-citation xml:lang="en">Bose S., Loo L.K., Rajabally Y.A. Causes and consequences of diagnostic delay in Guillain-Barré syndrome in a UK tertiary center. Muscle Nerve. 2022;65(5):547–552. https://doi.org/10.1002/mus.27506</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Lee H.S., Suh B.C., Kim J.K., Kim B.J., Nam T.S., Oh J., Bae J.S., Shin K.J., Kim S.W., Kim S.M., Shin H.Y. Serial Nerve Conduction Studies in Guillain-Barré Syndrome: Its Usefulness and Precise Timing. J Clin Neurophysiol. 2024;41(3):278–284. https://doi.org/10.1097/WNP.0000000000000985</mixed-citation><mixed-citation xml:lang="en">Lee H.S., Suh B.C., Kim J.K., Kim B.J., Nam T.S., Oh J., Bae J.S., Shin K.J., Kim S.W., Kim S.M., Shin H.Y. Serial Nerve Conduction Studies in Guillain-Barré Syndrome: Its Usefulness and Precise Timing. J Clin Neurophysiol. 2024;41(3):278–284. https://doi.org/10.1097/WNP.0000000000000985</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Rath J., Schober B., Zulehner G., Grisold A., Krenn M., Cetin H., Zimprich F. Nerve conduction studies in Guillain-Barré syndrome: Influence of timing and value of repeated measurements. J Neurol Sci. 2021;420:117267. https://doi.org/10.1016/j.jns.2020.117267</mixed-citation><mixed-citation xml:lang="en">Rath J., Schober B., Zulehner G., Grisold A., Krenn M., Cetin H., Zimprich F. Nerve conduction studies in Guillain-Barré syndrome: Influence of timing and value of repeated measurements. J Neurol Sci. 2021;420:117267. https://doi.org/10.1016/j.jns.2020.117267</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">He S., Lin Y. Application and Value of Limbs Peripheral Nerve Ultrasound in Guillain-Barre Syndrome. Altern Ther Health Med. 2024;30(10):416–421. https://alternative-therapies.com/oa/index.html?fid=9248. (доступ не ограничен)</mixed-citation><mixed-citation xml:lang="en">He S., Lin Y. Application and Value of Limbs Peripheral Nerve Ultrasound in Guillain-Barre Syndrome. Altern Ther Health Med. 2024;30(10):416–421. https://alternative-therapies.com/oa/index.html?fid=9248. (доступ не ограничен)</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Umapathi T., Lim C.S.J., Ng B.C.J., Goh E.J.H., Ohnmar O. A Simplified, Graded, Electrodiagnostic Criterion for Guillain-Barré Syndrome That Incorporates Sensory Nerve Conduction Studies. Sci Rep. 2019;9(1):7724. https://doi.org/10.1038/s41598-019-44090-w</mixed-citation><mixed-citation xml:lang="en">Umapathi T., Lim C.S.J., Ng B.C.J., Goh E.J.H., Ohnmar O. A Simplified, Graded, Electrodiagnostic Criterion for Guillain-Barré Syndrome That Incorporates Sensory Nerve Conduction Studies. Sci Rep. 2019;9(1):7724. https://doi.org/10.1038/s41598-019-44090-w</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Uncini A., Kuwabara S. The electrodiagnosis of Guillain-Barré syndrome subtypes: Where do we stand? Clin Neurophysiol. 2018;129(12):2586–2593. https://doi.org/10.1016/j.clinph.2018.09.025</mixed-citation><mixed-citation xml:lang="en">Uncini A., Kuwabara S. The electrodiagnosis of Guillain-Barré syndrome subtypes: Where do we stand? Clin Neurophysiol. 2018;129(12):2586–2593. https://doi.org/10.1016/j.clinph.2018.09.025</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">López-Hernández J.C., Galnares-Olalde J.A., Jorge de Saráchaga A., Briseño-Godínez M.E., Pérez-Valdez E., May-Mas R.N., Arista-Ramírez J.L., Bazán-Rodríguez L., León-Manriquez E., Burgos-Centeno J., Vargas-Cañas E.S. Very low peroneal nerve compound muscle action potential amplitude predicts poor outcome in patients with Guillain-Barré syndrome: a prospective cohort. Neurol Sci. 2022;43(6):3923–3928. https://doi.org/10.1007/s10072-021-05834-7</mixed-citation><mixed-citation xml:lang="en">López-Hernández J.C., Galnares-Olalde J.A., Jorge de Saráchaga A., Briseño-Godínez M.E., Pérez-Valdez E., May-Mas R.N., Arista-Ramírez J.L., Bazán-Rodríguez L., León-Manriquez E., Burgos-Centeno J., Vargas-Cañas E.S. Very low peroneal nerve compound muscle action potential amplitude predicts poor outcome in patients with Guillain-Barré syndrome: a prospective cohort. Neurol Sci. 2022;43(6):3923–3928. https://doi.org/10.1007/s10072-021-05834-7</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Sung E.J., Kim D.Y., Chang M.C., Ko E.J. Prediction of Functional Outcome in Axonal Guillain-Barre Syndrome. Ann Rehabil Med. 2016;40(3):481–488. https://doi.org/10.5535/arm.2016.40.3.481</mixed-citation><mixed-citation xml:lang="en">Sung E.J., Kim D.Y., Chang M.C., Ko E.J. Prediction of Functional Outcome in Axonal Guillain-Barre Syndrome. Ann Rehabil Med. 2016;40(3):481–488. https://doi.org/10.5535/arm.2016.40.3.481</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Naresh K., Roy A., Srivastava S., Premkumar P., Nair A., Mani A.M., Shaikh A., Thirumal P.A., Sivadasan A., Mathew V., Premkumar P.S., Benjamin R. Sensitivity and specificity of phrenic nerve electrophysiology to predict mechanical ventilation in the Guillain-Barré syndrome. Muscle Nerve. 2023;68(2):191–197. https://doi.org/10.1002/mus.27918</mixed-citation><mixed-citation xml:lang="en">Naresh K., Roy A., Srivastava S., Premkumar P., Nair A., Mani A.M., Shaikh A., Thirumal P.A., Sivadasan A., Mathew V., Premkumar P.S., Benjamin R. Sensitivity and specificity of phrenic nerve electrophysiology to predict mechanical ventilation in the Guillain-Barré syndrome. Muscle Nerve. 2023;68(2):191–197. https://doi.org/10.1002/mus.27918</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Pasutharnchat N., Ratanasirisawad V., Santananukarn M., Taychargumpoo C., Amornvit J., Chunharas C. Sural-sparing pattern: A study against electrodiagnostic subtypes of Guillain-Barre syndrome. Clin Neurophysiol Pract. 2022;7:266–272. https://doi.org/10.1016/j.cnp.2022.09.001</mixed-citation><mixed-citation xml:lang="en">Pasutharnchat N., Ratanasirisawad V., Santananukarn M., Taychargumpoo C., Amornvit J., Chunharas C. Sural-sparing pattern: A study against electrodiagnostic subtypes of Guillain-Barre syndrome. Clin Neurophysiol Pract. 2022;7:266–272. https://doi.org/10.1016/j.cnp.2022.09.001</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Liu L., Ye Y., Wang L., Song X., Cao J., Qi Y., Xing Y. Nerve ultrasound evaluation of Guillain-Barré syndrome subtypes in northern China. Muscle Nerve. 2021;64(5):560–566. https://doi.org/10.1002/mus.27386</mixed-citation><mixed-citation xml:lang="en">Liu L., Ye Y., Wang L., Song X., Cao J., Qi Y., Xing Y. Nerve ultrasound evaluation of Guillain-Barré syndrome subtypes in northern China. Muscle Nerve. 2021;64(5):560–566. https://doi.org/10.1002/mus.27386</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Mori A., Nodera H., Takamatsu N., Maruyama-Saladini K., Osaki Y., Shimatani Y., Kaji R. Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome. J Neurol Sci. 2016;364:154–159. https://doi.org/10.1016/j.jns.2016.03.042</mixed-citation><mixed-citation xml:lang="en">Mori A., Nodera H., Takamatsu N., Maruyama-Saladini K., Osaki Y., Shimatani Y., Kaji R. Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome. J Neurol Sci. 2016;364:154–159. https://doi.org/10.1016/j.jns.2016.03.042</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Пирадов М.А., Супонева Н.А., Гришина Д.А., Гнедовская Е.В. Качество жизни и социальная адаптация пациентов после синдрома Гийена–Барре. Журнал неврологии и психиатрии им. С.С. Корсакова. 2013;8:61–67. https://www.mediasphera.ru/myfirst_app/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2013/8/031997-72982013811 (доступ не ограничен).</mixed-citation><mixed-citation xml:lang="en">Piradov M.A., Suponeva N.A., Grishina D.A., Gnedovskaya E.V. Quality of life and social adaptation of patients with Guillain-Barré syndrome. S.S. Korsakov Journal of Neurology and Psychiatry (Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova). 2013;113(8):61-67 (Russian). https://www.mediasphera.ru/myfirst_app/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2013/8/031997-72982013811 (доступ не ограничен).</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Shang P., Feng J., Wu W., Zhang H.L. Intensive Care and Treatment of Severe Guillain-Barré Syndrome. Front Pharmacol. 2021;12:608130. https://doi.org/10.3389/fphar.2021.608130</mixed-citation><mixed-citation xml:lang="en">Shang P., Feng J., Wu W., Zhang H.L. Intensive Care and Treatment of Severe Guillain-Barré Syndrome. Front Pharmacol. 2021;12:608130. https://doi.org/10.3389/fphar.2021.608130</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Zaki H.A., Iftikhar H., Najam M., Masood M., Al-Marri N.D.R., Elgassim M., Fayed M., Shaban E.E. Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis. eNeurologicalSci. 2023;31:100468. https://doi.org/10.1016/j.ensci.2023.100468</mixed-citation><mixed-citation xml:lang="en">Zaki H.A., Iftikhar H., Najam M., Masood M., Al-Marri N.D.R., Elgassim M., Fayed M., Shaban E.E. Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis. eNeurologicalSci. 2023;31:100468. https://doi.org/10.1016/j.ensci.2023.100468</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Nandeesha S.S., Kasagga A., Hawrami C., Ricci E., Hailu K.T., Salib K., Butt S. Treatment Efficacy of Plasmapheresis Versus Intravenous Immunoglobulin in Guillain-Barré Syndrome Management: A Systematic Review. Cureus. 2024;16(3):e57066. https://doi.org/10.7759/cureus.57066</mixed-citation><mixed-citation xml:lang="en">Nandeesha S.S., Kasagga A., Hawrami C., Ricci E., Hailu K.T., Salib K., Butt S. Treatment Efficacy of Plasmapheresis Versus Intravenous Immunoglobulin in Guillain-Barré Syndrome Management: A Systematic Review. Cureus. 2024;16(3):e57066. https://doi.org/10.7759/cureus.57066</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Haridy N.A., Shehab M.M., Khedr E.M. Long-term outcomes of plasma exchange versus intravenous immunoglobulin for the treatment of Guillain-Barré Syndrome: A double-blind, randomized clinical trial. Restor Neurol Neurosci. 2023;41(5-6):203–217. https://doi.org/10.3233/RNN-231369</mixed-citation><mixed-citation xml:lang="en">Haridy N.A., Shehab M.M., Khedr E.M. Long-term outcomes of plasma exchange versus intravenous immunoglobulin for the treatment of Guillain-Barré Syndrome: A double-blind, randomized clinical trial. Restor Neurol Neurosci. 2023;41(5-6):203–217. https://doi.org/10.3233/RNN-231369</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Bondi M., Engel-Haber E., Wolff J., Grosman-Rimon L., Bloch A., Zeilig G. Functional outcomes following inpatient rehabilitation of Guillain-Barré syndrome patients: Intravenous immunoglobulins versus plasma exchange. Neurorehabilitation. 2021;48(4):543–551. https://doi.org/10.3233/NRE-201640</mixed-citation><mixed-citation xml:lang="en">Bondi M., Engel-Haber E., Wolff J., Grosman-Rimon L., Bloch A., Zeilig G. Functional outcomes following inpatient rehabilitation of Guillain-Barré syndrome patients: Intravenous immunoglobulins versus plasma exchange. Neurorehabilitation. 2021;48(4):543–551. https://doi.org/10.3233/NRE-201640</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Hughes R.A.C. Guillain-Barré syndrome: History, pathogenesis, treatment, and future directions. Eur J Neurol. 2024;31(11):e16346. https://doi.org/10.1111/ene.16346</mixed-citation><mixed-citation xml:lang="en">Hughes R.A.C. Guillain-Barré syndrome: History, pathogenesis, treatment, and future directions. Eur J Neurol. 2024;31(11):e16346. https://doi.org/10.1111/ene.16346</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Shastri A., Al Aiyan A., Kishore U., Farrugia M.E. Immune-Mediated Neuropathies: Pathophysiology and Management. Int J Mol Sci. 2023;24(8):7288. https://doi.org/10.3390/ijms24087288</mixed-citation><mixed-citation xml:lang="en">Shastri A., Al Aiyan A., Kishore U., Farrugia M.E. Immune-Mediated Neuropathies: Pathophysiology and Management. Int J Mol Sci. 2023;24(8):7288. https://doi.org/10.3390/ijms24087288</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Busl K.M., Fried H., Muehlschlegel S., Wartenberg K.E., Rajajee V., Alexander S.A., Creutzfeldt C.J., Fontaine G.V., Hocker S.E., Hwang D.Y., Kim K.S., Madzar D., Mahanes D., Mainali S., Meixensberger J., Sakowitz O.W., Varelas P.N., Westermaier T., Weimar C. Guidelines for Neuroprognostication in Adults with Guillain-Barré Syndrome. Neurocrit Care. 2023;38:564–583. https://doi.org/10.1007/s12028-023-01707-3</mixed-citation><mixed-citation xml:lang="en">Busl K.M., Fried H., Muehlschlegel S., Wartenberg K.E., Rajajee V., Alexander S.A., Creutzfeldt C.J., Fontaine G.V., Hocker S.E., Hwang D.Y., Kim K.S., Madzar D., Mahanes D., Mainali S., Meixensberger J., Sakowitz O.W., Varelas P.N., Westermaier T., Weimar C. Guidelines for Neuroprognostication in Adults with Guillain-Barré Syndrome. Neurocrit Care. 2023;38:564–583. https://doi.org/10.1007/s12028-023-01707-3</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Bazaraa H.M., Rady H.I., Mohamed S.A., Rabie W.A., ElAnwar N.H. Initial Response and Outcome of Critically Ill Children With Guillain Barre’ Syndrome. Front Pediatr. 2019;7:378. https://doi.org/10.3389/fped.2019.00378</mixed-citation><mixed-citation xml:lang="en">Bazaraa H.M., Rady H.I., Mohamed S.A., Rabie W.A., ElAnwar N.H. Initial Response and Outcome of Critically Ill Children With Guillain Barre’ Syndrome. Front Pediatr. 2019;7:378. https://doi.org/10.3389/fped.2019.00378</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Bhagwat A.P., Sharath H.V., Warghat P.A. Effect of Paediatric Rehabilitation in Children With Guillain-Barré Syndrome: A Case Series. Cureus. 2024;16(5):e59815. https://doi.org/10.7759/cureus.59815</mixed-citation><mixed-citation xml:lang="en">Bhagwat A.P., Sharath H.V., Warghat P.A. Effect of Paediatric Rehabilitation in Children With Guillain-Barré Syndrome: A Case Series. Cureus. 2024;16(5):e59815. https://doi.org/10.7759/cureus.59815</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Пономаренко Г.Н. Физиотерапия: перспективы системного развития. Вопросы курортологии, физиотерапии и лечебной физической культуры. 2017;94(6):59-64. https://doi.org/10.17116/kurort201794659-64</mixed-citation><mixed-citation xml:lang="en">Ponomarenko GN. Physical therapy: the prospects for its systemic development. Problems of Balneology, Physiotherapy and Exercise Therapy (Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul’tury). 2017;94(6):59-64 (Russian). https://doi.org/10.17116/kurort201794659-64</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Arya N.P., Seth N.H., Raghuveer R., Sewani Y. Exploring the Efficacy of Physiotherapy in Guillain-Barré Syndrome Through Virtual Reality-Based Rehabilitation: A Case Report. Cureus. 2024;16(4):e59042. https://doi.org/10.7759/cureus.59042</mixed-citation><mixed-citation xml:lang="en">Arya N.P., Seth N.H., Raghuveer R., Sewani Y. Exploring the Efficacy of Physiotherapy in Guillain-Barré Syndrome Through Virtual Reality-Based Rehabilitation: A Case Report. Cureus. 2024;16(4):e59042. https://doi.org/10.7759/cureus.59042</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Agnihotri S., Srivastava A., Gupta D., Naeem F. Rehabilitation of a Chronic Guillain-Barré Syndrome Patient With Vibratory Motor Stimulation of Dorsiflexors: A Case Report. Cureus. 2024;16(2):e53936. https://doi.org/10.7759/cureus.53936</mixed-citation><mixed-citation xml:lang="en">Agnihotri S., Srivastava A., Gupta D., Naeem F. Rehabilitation of a Chronic Guillain-Barré Syndrome Patient With Vibratory Motor Stimulation of Dorsiflexors: A Case Report. Cureus. 2024;16(2):e53936. https://doi.org/10.7759/cureus.53936</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Gawande I., Akhuj A., Samal S.. Effectiveness of Physiotherapy Intervention in Guillain Barre Syndrome: A Case Report. Cureus. 2024;16(1):e52062. https://doi.org/10.7759/cureus.52062</mixed-citation><mixed-citation xml:lang="en">Gawande I., Akhuj A., Samal S.. Effectiveness of Physiotherapy Intervention in Guillain Barre Syndrome: A Case Report. Cureus. 2024;16(1):e52062. https://doi.org/10.7759/cureus.52062</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Kariya G., Salphale V.G., Dadgal R. Effectiveness of Symptomatic Physiotherapy in Enhancing the Psychological Parameters of a Patient With Guillain-Barré Syndrome: A Case Report. Cureus. 2024;16(3):e55389. https://doi.org/10.7759/cureus.55389</mixed-citation><mixed-citation xml:lang="en">Kariya G., Salphale V.G., Dadgal R. Effectiveness of Symptomatic Physiotherapy in Enhancing the Psychological Parameters of a Patient With Guillain-Barré Syndrome: A Case Report. Cureus. 2024;16(3):e55389. https://doi.org/10.7759/cureus.55389</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Uz F.B., Uz C., Karaahmet O.Z. Three-year follow-up outcomes of adult patients with Guillain-Barré Syndrome after rehabilitation. Malawi Med J. 2023;35(3):156–162. https://doi.org/10.4314/mmj.v35i3.4</mixed-citation><mixed-citation xml:lang="en">Uz F.B., Uz C., Karaahmet O.Z. Three-year follow-up outcomes of adult patients with Guillain-Barré Syndrome after rehabilitation. Malawi Med J. 2023;35(3):156–162. https://doi.org/10.4314/mmj.v35i3.4</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Касьяненко К.В., Козлов К.В., Жданов К.В., Лапиков И.И., Беликов В.В. Прогноз степени тяжести течения SARS-CoV-2-инфекции у лиц молодого возраста с применением методов искусственного интеллекта. Журнал инфектологии. 2022;14(5):14–25. https://doi.org/10.22625/2072-6732-2022-14-5-14-25</mixed-citation><mixed-citation xml:lang="en">Kas’janenko K.V., Kozlov K.V., Zhdanov K.V., Lapikov I.I., Belikov V.V. SARS-CoV-2 severity prediction in young adults using artificial intelligence. Journal Infectology (Zhurnal infektologii). 2022;14(5):14–25 (Russian). https://doi.org/10.22625/2072-6732-2022-14-5-14-25</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Супонева Н.А., Мочалова Е.Г., Гришина Д.А., Пирадов М.А. Особенности течения СГБ в России: анализ 186 случаев. Нервно-мышечные болезни. 2014;(1):37–46. https://doi.org/10.17650/2222-8721-2014-0-1-40-47</mixed-citation><mixed-citation xml:lang="en">Suponeva N.A., Mochalova E.G., Grishina D.A., Piradov M.A. The specific features of Guillain–Barré syndrome in Russia: Analysis of 186 cases. Neuromuscular Diseases (Nervno-myshechnye bolezni). 2014;(1):37–46 (Russian). https://doi.org/10.17650/2222-8721-2014-0-1-40-47</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Козырева А.А., Бембеева Р.Ц., Дружинина Е.С., Заваденко Н.Н. Синдром Гийена-Барре у детей. Журнал неврологии и психиатрии им. С.С. Корсакова. 2023;123(9-2):20–32. https://doi.org/10.17116/jnevro202312309220</mixed-citation><mixed-citation xml:lang="en">Kozyreva AA, Bembeeva RTs, Druzhinina ES, Zavadenko NN. Guillain—Barre syndrome in children. S.S. Korsakov Journal of Neurology and Psychiatry (Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova). 2023;123(9-2):20-32 (Russian). https://doi.org/10.17116/jnevro202312309220</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
